View More View Less
  • 1 Uzsoki Utcai Kórház, Budapest, Uzsoki u. 29–41., 1145
  • 2 Szent Borbála Kórház, Tatabánya, Dózsa Gy. út 77., 2800
Open access

Absztrakt:

Bevezetés: Hazánkban a colorectalis carcinoma a második leggyakoribb daganatos halálozási ok. Legfontosabb prognosztikai tényező a teljes túlélés szempontjából az operabilitás, valamint a műtét technikai minősége. A végbélrák műtéti „gold standardja” a teljes mesorectum excisio, mely a betegek egy részénél alkati sajátságokból és anatómiai viszonyokból adódóan laparoszkópos módszerrel gyakran nehezen vagy inkomplett módon kivitelezhető. Egy új műtéti koncepció, a transanalis teljes mesorectum excisio (TaTME) azonban megoldást jelenthet erre a problémára, felhasználva a legmodernebb sebészeti technika nyújtotta lehetőségeket. Célkitűzés: Az új műtéti technika hazai bevezetésének, kezdeti tapasztalatainak bemutatása. Módszer: Az új eljárást Magyarországon az elsők között két munkacsoport alkalmazta. Egyéves esetsorozatuk tapasztalatait retrospektíve elemeztük. Eredmények: A szerzői munkacsoportok összesen 17 transanalis teljes mesorectum excisio (TaTME) műtétet végeztek. Súlyos intra- vagy posztoperatív szövődmény 2 esetben fordult elő. Perioperatív halálozás nem történt. Végleges colostoma képzésére 3 esetben került sor. Következtetés: Közleményünk az alsó és középső harmadi végbéldaganatok transanalis teljes mesorectalis excisiójával szerzett első hazai tapasztalatokat ismerteti. A korai klinikai eredmények a rectumcarcinoma sebészetének egy forradalmian új korszakát vetítik előre. Orv Hetil. 2018; 159(1): 16–22.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Eurostat. Causes of death statistics 2015. [Daganatos mortalitási mutatók 2015.] Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Causes_of_death_statistics/hu [Hungarian]

  • 2

    NIH. Cancer Stat Facts: Colon and Rectum Cancer. Available from: https://seer.cancer.gov/statfacts/html/colorect.html

  • 3

    Gietelink L, Henneman D, van Leersum NJ, et al., on behalf of the Dutch Surgical Colorectal Cancer Audit Group. The influence of hospital volume on circumferential resection margin involvement: results of the Dutch Surgical Colorectal Audit. Ann Surg. 2016; 263: 745–750.

  • 4

    Cleveland Clinic. Colorectal Cancer: Prognosis/Outlook. Available from: https://my.clevelandclinic.org/health/articles/prognosis-outlook-for-people-with-colorectal-cancer

  • 5

    Plummer JM, Williams N, Leake PA, et al. Surgical quality in colorectal cancer. Ann Med Surg. 2016; 5: 52–56.

  • 6

    Bilchik A, Nissan A, Wainberg Z, et al. Surgical quality and nodal ultra-staging is associated with long-term disease-free survival in early colorectal cancer: an analysis of two international multi-center prospective trials. Ann Surg. 2010; 252: 467–476.

  • 7

    Archampong D, Borowski D, Wille-Jørgensen P, et al. Workload and surgeon’s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012; 14: CD005391.

  • 8

    Quirke P, Steele R, Monson J, et al., on behalf of the MRC CR07/NCIC-CTG CO16 trial investigators, the NCRI colorectal cancer study group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373: 821–828.

  • 9

    Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg. 1982; 69: 613–616.

  • 10

    Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998; 133: 894–899.

  • 11

    Moszkowicz D, Alsaid B, Bessede T, et al. Where does pelvic nerve injury occur during rectal surgery for cancer? Colorectal Dis. 2011; 13: 1326–1334.

  • 12

    Martling AL, Holm T, Rutqvist LE, et al., for the Stockholm Colorectal Cancer Study Group and the Basingstoke Bowel Cancer Research Project. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93–96.

  • 13

    Martling A, Holm T, Rutqvist LE, et al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2005; 92: 225–229.

  • 14

    Chen B, Zhang Y, Zhao S, et al. The impact of general/visceral obesity on completion of mesorectum and perioperative outcomes of laparoscopic TME for rectal cancer: A STARD-compliant article. Medicine (Baltimore) 2016; 95: e4462.

  • 15

    Zur Hausen G, Gröne J, Kaufmann D, et al. Influence of pelvic volume on surgical outcome after low anterior resection for rectal cancer. Int J Colorectal Dis. 2017; 32: 1125–1135.

  • 16

    Bonjer HJ, Deijen CL, Abis GA, et al., for the COLOR II Sudy Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015; 372: 1324–1332.

  • 17

    Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: The ACOSOG Z6051 randomized clinical trial. JAMA 2015; 314: 1346–1355.

  • 18

    Stevenson AR, Solomon MJ, Lumley JW, et al., for the ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: The ALaCaRT randomized clinical trial. JAMA 2015; 314: 1356–1363.

  • 19

    van der Pas MH, Deijen CL, Abis GS, et al., for the Color II study group. Conversions in laparoscopic surgery for rectal cancer. Surg Endosc. 2017; 31: 2263–2270.

  • 20

    Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010; 24: 1205–1210.

  • 21

    Chen WH, Kang L, Luo SL, et al. Transanal total mesorectal excision assisted by single-port laparoscopic surgery for low rectal cancer. Tech Coloproctol. 2015; 19: 527–534.

  • 22

    Simillis C, Hompes R, Penna M, et al. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis. 2016; 18: 19–36.

  • 23

    Perdawood SK, Khefagie GA. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis. 2016; 18: 51–58.

  • 24

    Deijen CL, Velthuis S, Tsai A, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2016; 30: 3210–3215.

  • 25

    Bánky B, Járay G. TAMIS, transanal minimally invasive surgery. [TAMIS, transanalis minimálisan invazív sebészet.] Magy Seb. 2016; 69: 105–112. [Hungarian]

  • 26

    Hasegawa S, Okada T, Hida K, et al. Transperineal minimally invasive approach for extralevator abdominoperineal excision. Surg Endosc. 2016; 30: 4620–4621.

  • 27

    West NP, Anderin C, Smith KJ, et al. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010; 97: 588–599.

  • 28

    Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications. Ann Surg. 2004; 240: 205–213.

  • 29

    Papp G, Besznyák I, Pörneczi B, et al. Advantages of transanal approach in low rectal cancer resections. [A transanalis megközelítés előnye a mély rectumdaganatok műtéteinél.] Magy Seb. 2017; 70: 119–124. [Hungarian]

  • 30

    Deijen CL, Tsai A, Koedam TW, et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol. 2016; 20: 811–824.

  • 31

    Xu W, Xu Z, Cheng H, et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol. 2016; 42: 1841–1850.

  • 32

    Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 2016; 16: 380.

  • 33

    Penna M, Hompes R, Arnold S, et al., on behalf of the TaTME Registry Collaborative. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2017; 266: 111–117.

  • 34

    Koedam TW, van Ramshorst GH, Deijen CL, et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol. 2017; 21: 25–33.

  • 35

    Francis N, Penna M, Mackenzie H, et al., The International TaTME Educational Collaborative Group. Consensus on structured training curriculum for transanal total mesorectal excision (TaTME). Surg Endosc. 2017; 31: 2711–2719.

  • 36

    TaTME Registry. Available from: https://tatme.medicaldata.eu

  • 37

    Atallah S. Transanal total mesorectal excision: full steam ahead. Tech Coloproctol. 2015; 19: 57–61.

  • 38

    Colorectal screening is launched nationwide. March 7, 2017. [Országossá teszik a vastagbélszűrési programot. 2017. március 7.] Available from: http://www.kormany.hu/hu/emberi-eroforrasok-miniszteriuma/hirek/orszagossa-teszik-a-vastagbelszuresi-programot [Hungarian]

 

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

 

Mendeley citation style is available HERE.
  • Impact Factor (2019): 0.497
  • Scimago Journal Rank (2018): 0.176
  • SJR Hirsch-Index (2018): 20
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)
  • Impact Factor (2018): 0.564
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu